GSK plc operates as a focused, science-led biopharmaceutical company with a global footprint. The company organizes its business into three primary segments: Specialty Medicines, Vaccines, and General Medicines. Its specialty portfolio includes treatments for HIV, oncology, and immune-inflammation diseases, while its general medicines segment provides widely used therapies for respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). GSK is also one of the world's largest vaccine manufacturers, producing immunizations for shingles, RSV, meningitis, and influenza. Following the demerger of its consumer healthcare business, Haleon, in 2022, GSK has concentrated its capital and R&D efforts entirely on advanced biopharmaceuticals and infectious disease prevention.
